Medical News

RSS

To achieve MDGs, economic policies must help poor, UNDP head says

Economic policies that help the poor will bring the world closer to meeting the Millennium Development Goals [MDGs] - "[g]lobal targets to halve poverty and improve basic health by 2015," Helen Clark, the U.N. Development Programme (UNDP) administrator, said Friday at the end of a four-nation tour of Africa, Agence France-Presse reports.

17 May 2010

WaferGen Biosystems first-quarter revenues increase to $389,785

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genome analysis systems, today reported performance results for the first quarter ended March 31, 2010.

17 May 2010

Medicare cuts for physicians loom, yet again

A 21 percent reduction in Medicare reimbursements that has loomed over physicians all year will go into effect on June 1, unless Congress acts to further delay the cuts, CNNMoney reports. "If the proposed cuts go through, physicians are worried their practices will be so strapped that they'll have to drop some of the 43 million Americans who are covered under Medicare."

17 May 2010

Highwoods Properties, INC Research expand relationship

Highwoods Properties, Inc., the largest owner and operator of suburban office properties in the Southeast, today announced that it has expanded its relationship with INC Research®, Inc., a therapeutically focused contract research organization that conducts global clinical development programs.

17 May 2010

KHN Column: The health care cost problem we refuse to see

In his latest Kaiser Health News column, Austin Frakt writes: "I agree with those who think the Patient Protection and Affordable Care Act doesn't do enough soon enough to control the rate of increase in health insurance premiums.

17 May 2010

Hawthorn announces licensing deal with University of Pittsburgh for novel monoclonal antibodies for cancer

Hawthorn Pharmaceuticals, Inc. today announced a global licensing deal with the University of Pittsburgh covering a series of novel monoclonal antibodies for cancer. The antibody portfolio targets a variety of cancers through the cell surface chondrotin sulfate proteoglycan 4 (CSPG4), which plays an important role in signaling pathways regulating tumor cell survival, growth, and motility.

17 May 2010

Health law's affect on ERs, doctors' panel, young adults examined

Officials and stakeholders are examining the new health reform law for changes that the reform will mean for their organizations and industries.

17 May 2010

BaroFold licenses PreEMT Technology to Nuron Biotech for development of BaroFeron

BaroFold, Inc. today announced that it has entered into an agreement to exclusively license its PreEMT™ Technology to Nuron Biotech for the development of BaroFeron™ and follow-on interferon beta products. BaroFeron is a proprietary recombinant human interferon beta being developed for the treatment of multiple sclerosis. Specific terms of the agreement are not disclosed.

17 May 2010

Health Robotics re-acquires European rights for CytoCare from B. Braun

Health Robotics and B. Braun Melsungen AG today announced that in exchange for undisclosed consideration, Health Robotics has re-acquired from B. Braun the exclusive marketing, sales, installation, implementation, interface, manufacturing, and technical support European rights for CytoCare, a robot designed to manufacture chemotherapy and hazardous IV Admixtures, and which rights B. Braun had previously acquired from Health Robotics in 2007 and 2008.

From B. Braun Melsungen AG 17 May 2010

Today's Opinions and Editorials: Support for Berwick and health reform's next tests

He is well-qualified to make the many crucial decisions surrounding Medicare and Medicaid, and could end up being one of the most significant appointees in the administration (5/17).

17 May 2010

Mpex Pharmaceuticals presents Phase 2b trial results of Aeroquin for cystic fibrosis at ATS Annual Meeting

Mpex Pharmaceuticals, Inc. today announced the presentation of data from its Phase 2b clinical trial with Aeroquin™ (a proprietary aerosol formulation of levofloxacin, MP-376) in cystic fibrosis (CF) at the American Thoracic Society (ATS) Annual Meeting in New Orleans.

17 May 2010

Hospitals to get more bargaining clout for medical devices

The Wall Street Journal: "Hospitals lack leverage when negotiating prices for high-cost implants like defibrillators and replacement hips because individual doctors, rather than hospitals, typically select the products they use in their patients. Since these doctors often aren't hospital employees, they have little incentive to bargain-hunt.

17 May 2010

Dehaier Medical Systems becomes exclusive China distributor of Welch Allyn's patient monitors

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical products in China, said today that it has become the exclusive China distributor of Welch Allyn's patient monitors.

17 May 2010

IRS to announce tax credit rules for small business health premiums

The Associated Press: "Pitching President Barack Obama's health care law to skeptical business owners, the IRS on Monday will announce ground rules for small firms wishing to claim a new federal tax credit for health insurance." The tax credit, which was created by the new health overhaul law, "covers up to 35 percent of the premiums that certain small businesses pay on behalf of their workers.

17 May 2010

Del Global Technologies files registration statement with SEC for rights offering

Del Global Technologies Corp. today announced that it filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a rights offering to its existing shareholders. The rights offering will be made through the distribution of non-transferable subscription rights to purchase shares of the Company's common stock, par value $0.10 per share, at a subscription price to be determined.

17 May 2010

Dartmouth to start health care delivery research center

"Dartmouth College is getting $35 million to open a center it hopes will help the nation take the next big steps in health care reform: improving quality while lowering costs," The Associated Press reports.

17 May 2010

Aastrom Biosciences initiates treatment in Phase 2 catheter-based clinical trial for dilated cardiomyopathy

Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the first patient has been treated in the company's U.S. Phase 2 catheter-based clinical trial to treat dilated cardiomyopathy (DCM). Treatment was performed by interventional cardiologist Timothy D. Henry, M.D., FACC, at the Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis, MN.

17 May 2010

Emisphere Technologies first-quarter net loss increases to $18.5 million

Emisphere Technologies, Inc. today announced its financial results for the first quarter 2010.

17 May 2010

FDA grants NeoPharm's IL13-PE38QQR orphan-drug designation for treatment of IPF

NeoPharm, Inc., announced today that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan-drug designation for IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis (IPF).

17 May 2010

Communication Intelligence first-quarter total revenue decreases to $207,000

Communication Intelligence Corporation, a leading supplier of electronic signature solutions for business process automation in the financial industry and the recognized leader in biometric signature verification, announced today its financial results for the first quarter ended March 31, 2010.

17 May 2010

Medical News

To achieve MDGs, economic policies must help poor, UNDP head says

WaferGen Biosystems first-quarter revenues increase to $389,785

Medicare cuts for physicians loom, yet again

Highwoods Properties, INC Research expand relationship

KHN Column: The health care cost problem we refuse to see

Hawthorn announces licensing deal with University of Pittsburgh for novel monoclonal antibodies for cancer

Health law's affect on ERs, doctors' panel, young adults examined

BaroFold licenses PreEMT Technology to Nuron Biotech for development of BaroFeron

Health Robotics re-acquires European rights for CytoCare from B. Braun

Today's Opinions and Editorials: Support for Berwick and health reform's next tests

Mpex Pharmaceuticals presents Phase 2b trial results of Aeroquin for cystic fibrosis at ATS Annual Meeting

Hospitals to get more bargaining clout for medical devices

Dehaier Medical Systems becomes exclusive China distributor of Welch Allyn's patient monitors

IRS to announce tax credit rules for small business health premiums

Del Global Technologies files registration statement with SEC for rights offering

Dartmouth to start health care delivery research center

Aastrom Biosciences initiates treatment in Phase 2 catheter-based clinical trial for dilated cardiomyopathy

Emisphere Technologies first-quarter net loss increases to $18.5 million

FDA grants NeoPharm's IL13-PE38QQR orphan-drug designation for treatment of IPF

Communication Intelligence first-quarter total revenue decreases to $207,000

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Latest News